
Boehringer Ingelheim has signed a worldwide deal with Munich-based pharma firm Priaxon to find novel treatments for cancer. The firms …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

